SEC 13F Intelligence

Vida Ventures Advisors, LLC / KNTEUSD

Vida Ventures Advisors, LLC’s Kinnate Biopharma Inc Position

Does Vida Ventures Advisors, LLC own Kinnate Biopharma Inc (KNTEUSD)? Not currently — the last reported position was 2.21M shares worth $5M in Q4 2023; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$5M
Q4 2023
Shares
2.21M
% of Portfolio
+6.23%
Quarters Held
13
position exited

Position History KNTEUSD

Reported value by quarter
Q4 ’20: $109MQ4 ’20Q1 ’21: $86MQ2 ’21: $64MQ2 ’21Q3 ’21: $63MQ4 ’21: $49MQ4 ’21Q1 ’22: $31MQ2 ’22: $35MQ2 ’22Q3 ’22: $26MQ4 ’22: $13MQ4 ’22Q1 ’23: $14MQ2 ’23: $7MQ2 ’23Q3 ’23: $3MQ4 ’23: $5MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20232.21M$5M+6.23%
Q3 20232.21M$3M+4.78%
Q2 20232.21M$7M+8.73%
Q1 20232.21M$14M+18.88%
Q4 20222.21M$13M+18.10%
Q3 20222.21M$26M+23.68%
Q2 20222.75M$35M+29.28%
Q1 20222.75M$31M+17.99%
Q4 20212.75M$49M+18.21%
Q3 20212.75M$63M+18.11%
Q2 20212.75M$64M+16.04%
Q1 20212.75M$86M+21.63%
Q4 20202.75M$109M+22.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vida Ventures Advisors, LLC’s full portfolio or all institutional holders of KNTEUSD.